World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
13497
World Ranking
2864
National Ranking
257

Overview

Robert W. Baldwin was a researcher affiliated with the University of Nottingham in the United Kingdom. Their work spanned several intersecting fields of study, primarily focusing on environmental science, medicine, and earth and planetary sciences.

Their research covered subfields including ecology, infectious diseases, developmental biology, global and planetary change, and atmospheric science. Key topics addressed in their publications involved marine animal studies, animal vocal communication and behavior, marine and fisheries research, arctic and antarctic ice dynamics, underwater acoustics research, mosquito-borne diseases and control, as well as viral infections and vectors.

Their recent publications reflected this broad interdisciplinary approach. Notable papers include "Seasonal distribution, abundance, habitat use and population identity of humpback whales in Oman" (2020) published in "The journal of cetacean research and management. Special issue," "A new blue whale song-type described for the Arabian Sea and Western Indian Ocean" (2020) published in Endangered Species Research, and "The development and validation of a microneutralization assay for the detection and quantification of anti-yellow fever virus antibodies in human serum" (2025) published in Microbiology Spectrum.

Throughout their career, Baldwin collaborated frequently with several coauthors, including Gianna Minton, Salvatore Cerchio, Alexander B. Willson, Emmanuelle C. Leroy, and C R Muirhead.

Their work was published predominantly in venues such as Endangered Species Research, The journal of cetacean research and management. Special issue, and Microbiology Spectrum.

Best Publications

  • Monoclonal Antibodies for Cancer Detection and Therapy

    Robert William Baldwin;Vera S. Byers

  • The influence of tumour cell DNA abnormalities on survival in colorectal cancer.

    N. C. Armitage;R. A. Robins;D. F. Evans;D. R. Turner

  • Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

    R. W. Baldwin;M. R. Price;R. A. Robins

  • RADIOIMMUNODETECTION OF HUMAN COLORECTAL CANCERS BY AN ANTI-TUMOUR MONOCLONAL ANTIBODY

    P.A. Farrands;M.V. Pimm;M.J. Embleton;A.C. Perkins

  • Immunological Aspects Of Chemical Carcinogenesis

    Unknown

  • Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.

    M J Embleton;B Gunn;V S Byers;R W Baldwin

  • Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen

    R. W. Baldwin;M. R. Price;R. A. Robins

  • The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients.

    Malcolm V. Pimm;Alan C. Perkins;Nicholas C. Armitage;Robert W. Baldwin

  • A phase I/II study of trichosanthin treatment of HIV disease.

    Vera Byers;Alan Levin;Larry Waites;Barbara Starrett

  • Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro.

    M. C. Garnett;M. J. Embleton;E. Jacobs;R. W. Baldwin

  • Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia.

    V. S. Byers;V. S. Byers;A. S. Levin;D. M. Ozonoff;R. W. Baldwin

  • Immunological and structural features of the protein core of human polymorphic epithelial mucin.

    Michael R. Price;Ferenc Hudecz;Colette O'Sullivan;Robert W. Baldwin

  • Tumour‐specific immunity against spontneous rat tumours

    R. W. Baldwin

  • Circulating immune complexes in patients with breast cancer.

    K Hoffken;I D Meredith;R A Robins;R W Baldwin

  • Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.

    V S Byers;R Rodvien;K Grant;L G Durrant

  • In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.

    M. V. Pimm;M. J. Embleton;A. C. Perkins;M. R. Price

  • Tumour‐specific antigenicity of aminoazo‐dye‐induced rat hepatomas

    R. W. Baldwin;C. R. Barker

  • Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate.

    M. J. Embleton;G. F. Rowland;R. G. Simmonds;E. Jacobs

  • Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte subsets.

    D A Cantrell;R A Robins;C G Brooks;R W Baldwin

  • Monoclonal antibodies in cancer treatment.

    R.W. Baldwin;VeraS. Byers

  • Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.

    R. W. Baldwin;M. J. Embleton;M. R. Price

Frequent Co-Authors

Lindy G. Durrant
Lindy G. Durrant University of Nottingham
Ian O. Ellis
Ian O. Ellis University of Nottingham
Roger W. Blamey
Roger W. Blamey Nottingham City Hospital
C.W. Elston
C.W. Elston University of Nottingham
Karl Erik Hellström
Karl Erik Hellström University of Washington
Ingegerd Hellström
Ingegerd Hellström University of Washington
Robert C. Rees
Robert C. Rees Nottingham Trent University
Siri Ram Chhabra
Siri Ram Chhabra University of Nottingham
Patricia J. McLaughlin
Patricia J. McLaughlin Pennsylvania State University
Dallas M. Swallow
Dallas M. Swallow University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to diverse healthcare careers, often bridging into nursing roles that complement immunological expertise. For those aiming to expand their nursing qualifications, exploring an accelerated FNP program can be a strategic step. These programs help licensed nurses quickly transition to Family Nurse Practitioner roles, enhancing their clinical scope.

Transitioning further into specialized acute care is possible through achieving acute care NP certification, which qualifies nurse practitioners to manage complex patient needs in critical settings. This pathway is valuable for immunology professionals seeking hands-on roles in patient care that demand advanced knowledge of immune-related health issues.

For individuals entering nursing without a background in the field, enrolling in online ABSN programs for non nurses provides a flexible route to start a nursing career. These programs are designed to equip non-nurses with the necessary skills, offering a foundation that supports further specialization in areas connected to immunology.

Understanding compensation is also crucial when planning your career trajectory. The how much does a DNP make resource offers detailed insights into salary variations by state for Doctor of Nursing Practice graduates, helping candidates make informed decisions about their education and career plans.

Best Scientists Citing Robert W. Baldwin

Recently Published Articles